FIELD: medicine.
SUBSTANCE: invention relates to a method for the production of a polymorphous form of sodium benzoate, which has a diffraction radiograph containing characteristic peaks at a reflection angle 2θ of 4.3, 5.9, 7.1, 8.6, 10.1, 10.7, 12.9, 13.8, 14.4, 17.2, 17.7, 18.5, 21.5, 22.0, 22.6, 23.7, 25.1, 25.9, 26.2, 26.9, 27.9, 28.2, 28.8, 29.1, 29.7, 30.2, 31.2, 33.2, 34.9, 35.8, 36.1, and 39.3.
EFFECT: method is developed for the production of a new polymorphous form of sodium benzoate, which can be used in the treatment and/or reduction in the risk of a neuropsychiatric disorder, for example, schizophrenia, psychotic disorders, depressive disorders, or Alzheimer’s disease.
5 cl, 24 dwg, 5 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS OF PRODUCTION ISOQUINOLINONES AND SOLID FORMS ISOQUINOLINONES | 2012 |
|
RU2626883C2 |
| SOLID FORMS OF 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR PHARMACEUTICAL COMPOSITIONS AND USE | 2012 |
|
RU2611007C2 |
| SODIUM BENZOATE COCRYSTALS AND THEIR USE | 2017 |
|
RU2771810C2 |
| DOSAGE FORMS, SALTS AND POLYMORPHS OF TRANSNORSERTRALINE AND USING THEM | 2010 |
|
RU2578956C2 |
| LITHIUM BENZOATE CO-CRYSTALS AND THEIR APPLICATIONS | 2017 |
|
RU2765625C2 |
| POLYMORPHIC FORMS OF (2S)-(4E)-N-METHYL-5-[3-(5-ISOPROPOXYPYRIDIN)YL]-4-PENTEN-2-AMIN FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | 2007 |
|
RU2440984C2 |
| SYNTHESIS AND NEW SALINE FORMS OF (R)-5-((E)-2-(PYRROLIDIN-3-YLVINYL)PYRIMIDINE | 2009 |
|
RU2533819C2 |
| NOVEL SOLID FORMS (2S,3S,4S,5R,6S)-3,4,5-TRIHYDROXY-6-(((4AR,10AR)-7-HYDROXY-1-PROPYL-1,2,3,4,4A,5,10,10A-OCTAHYDROBENZO[G]QUINOLIN-6-YL)OXY)TETRAHYDRO-2H-PYRAN-2-CARBOXYLIC ACID | 2020 |
|
RU2820501C2 |
| COMPOSITIONS CONTAINING BENZOATE COMPOUND AND TANNIC ACID FOR TREATMENT OF DISORDER OF CENTRAL NERVOUS SYSTEM | 2017 |
|
RU2756812C2 |
| CRYSTALLINE FORM OF (R)-7-CHLORO-N-(QUINUCLIDIN-3-YL)BENZO[b]THIOPHENE-2-CARBOXAMIDE HYDROCHLORIDE MONOHYDRATE | 2011 |
|
RU2577334C2 |
